Life sciences company Bio-Techne Corporation (NASDAQ: TECH) announced on Wednesday that its board of directors has approved a quarterly dividend of USD0.08 per share for Q3 2024.
This dividend is payable on 22 November 2024 to shareholders of record as of 11 November 2024.
The company said its board will continue to evaluate cash dividends on a quarterly basis.
Bio-Techne provides essential tools and reagents for research and clinical diagnostics, supporting drug discovery and accurate clinical testing. In fiscal 2024, the company reported USD1.2bn in net sales and employs approximately 3,100 people worldwide.
hVIVO acquires German Clinical Research Units for EUR10m; Targets earnings growth by 2026
OptiBiotix expands into Indian market with Amazon launch
Poxel to receive royalties and sales-based payment from Sumitomo Pharma
ReciBioPharm secures grant to expand RNA manufacturing in LMICs
CVS Health to pays common stock quarterly dividend of USD0.665 per share
TC BioPharm receives shareholders' approval for 25% stock dividend
USANA Health Sciences acquires controlling stake in Hiya Health for USD205m
Valneva and Serum Institute of India partner to expand chikungunya vaccine access in Asia
Lilly and EVA Pharma granted regulatory approval for locally manufactured insulin in Egypt
SK bioscience begins clinical trials for mRNA Japanese encephalitis vaccine
Moberg Pharma's MOB-015 fails to meet primary endpoint in phase 3 study
Valneva reports strong, long-lasting immunity from single-dose chikungunya vaccine
Lakeside's Sichuan Hupan to acquire Hupan Pharmaceutical
Cardinal Health to pay quarterly dividend of USD0.5056 per share